We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+18.44%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$845M
AUM Growth
+$279M
Cap. Flow
+$203M
Cap. Flow %
23.97%
Top 10 Hldgs %
63.74%
Holding
124
New
76
Increased
6
Reduced
15
Closed
19

Top Buys

Rank Stock Value
1
BUD icon
AB InBev
BUD
+$16.9M
2
SN icon
SharkNinja
SN
+$12.6M
3
AHR icon
American Healthcare REIT
AHR
+$9.21M
4
KSPI icon
Kaspi.kz JSC
KSPI
+$8.9M
5
ODD icon
ODDITY Tech
ODD
+$8.85M

Top Sells

Rank Stock Value
1
PCG icon
PG&E
PCG
+$4.69M
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$4.11M
3
GPCR icon
Structure Therapeutics
GPCR
+$4.1M
4
ARGX icon
argenx
ARGX
+$3.8M
5
LVS icon
Las Vegas Sands
LVS
+$3.69M

Sector Composition

Rank Sector Weight
1 Healthcare 15.07%
2 Industrials 5.62%
3 Consumer Staples 3.94%
4 Technology 3.82%
5 Consumer Discretionary 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BROS icon
76
Dutch Bros
BROS
$8.96B
$1.65M 0.2%
+50,000
New +$1.48M
DT icon
77
Dynatrace
DT
$14.6B
$1.63M 0.19%
+35,000
New +$1.82M
MSDL icon
78
Morgan Stanley Direct Lending Fund
MSDL
$1.28B
$1.56M 0.18%
+72,212
New +$1.49M
OLMA icon
79
Olema Pharmaceuticals
OLMA
$1.04B
$1.53M 0.18%
+135,000
New +$1.74M
PRCH icon
80
Porch Group
PRCH
$1.75B
$1.51M 0.18%
+350,000
New +$1.04M
MLNK
81
DELISTED
MeridianLink
MLNK
$1.5M 0.18%
+80,000
New +$1.63M
MRSN
82
DELISTED
Mersana Therapeutics
MRSN
$1.39M 0.16%
+12,400
New +$1.23M
UNCY icon
83
Unicycive Therapeutics
UNCY
$138M
$1.38M 0.16%
+100,000
New +$1.21M
PEPG icon
84
PepGen
PEPG
$207M
$1.26M 0.15%
+85,886
New +$1.01M
PRAX icon
85
Praxis Precision Medicines
PRAX
$10.2B
$1.22M 0.14%
+20,000
New +$897K
CDLX icon
86
Cardlytics
CDLX
$22.4M
$1.09M 0.13%
+7,500
New +$633K
CMPX icon
87
Compass Therapeutics
CMPX
$400M
$990K 0.12%
500,000
– –
STOK icon
88
Stoke Therapeutics
STOK
$2.08B
$912K 0.11%
+67,584
New +$409K
NVDA icon
89
NVIDIA
NVDA
$5.27T
$904K 0.11%
+10,000
New +$725K
MIST icon
90
Milestone Pharmaceuticals
MIST
$157M
$895K 0.11%
+500,000
New +$812K
BWMN icon
91
Bowman Consulting
BWMN
$743M
$870K 0.1%
+25,000
New +$861K
RWAY icon
92
Runway Growth Finance
RWAY
$278M
$848K 0.1%
70,000
-21,739
-24% -$280K
STVN icon
93
Stevanato
STVN
$5.62B
$642K 0.08%
+20,000
New +$609K
SOFI icon
94
SoFi Technologies
SOFI
$23.4B
$584K 0.07%
+80,000
New +$635K
FSBC icon
95
Five Star Bancorp
FSBC
$1.13B
$563K 0.07%
+25,000
New +$599K
BOLD
96
Boundless Bio
BOLD
$63.4M
$445K 0.05%
+31,250
New +$445K
NAMSW icon
97
NewAmsterdam Pharma Warrant
NAMSW
$79.1M
$344K 0.04%
+31,189
New +$284K
CDTX
98
DELISTED
Cidara Therapeutics
CDTX
$340K 0.04%
18,455
– –
KDP icon
99
Keurig Dr Pepper
KDP
$39.9B
$307K 0.04%
+10,000
New +$308K
MTEM
100
DELISTED
Molecular Templates, Inc.
MTEM
$236K 0.03%
105,493
-16,348
-13% -$55.1K
1 2 3
4
5

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, Monashee Investment Management held 124 positions worth $845M, up 49% from $567M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Monashee Investment Management deployed $203M of net new capital in Q1 2024, opening 76 new positions and adding to 6 existing holdings. Its largest new stake was AB InBev: 270,100 shares worth $16.4M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 9.1% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $4.11M trimmed.

  • Monashee Investment Management's largest Q1 2024 buy was AB InBev: 270,100 shares worth $16.4M.
  • Monashee Investment Management added most to Vaxcyte in Q1 2024, an estimated $4.33M increase.
  • Monashee Investment Management's biggest Q1 2024 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $4.11M.
  • Monashee Investment Management fully exited PG&E in Q1 2024, selling an estimated $4.69M.
  • Monashee Investment Management's ten largest holdings make up 64% of its $845M portfolio in Q1 2024.
  • Monashee Investment Management opened 76 new positions and closed 19 in Q1 2024.
  • Monashee Investment Management's portfolio value rose 49% quarter-over-quarter to $845M.

Based on Monashee Investment Management's 13F filing for Q1 2024, filed 14 May 2024.